欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是

中国临床药理学与治疗学 ›› 2022, Vol. 27 ›› Issue (2): 136-143.doi: 10.12092/j.issn.1009-2501.2022.02.003

• 基础研究 • 上一篇    下一篇

参芪扶正注射液干预低糖介导的免疫抑制微环境作用及其机制研究

马旺博1,2,马月1,2,范方田1,2,张语涵1,2,常静雯1,2,周智华1,2   

  1. 1蚌埠医学院药学院,蚌埠 233030,安徽;2安徽省生化药物工程技术研究中心,蚌埠 233030,安徽
  • 收稿日期:2021-11-08 修回日期:2022-01-28 出版日期:2022-02-26 发布日期:2022-03-09
  • 通讯作者: 范方田,男,副教授,硕士生导师,从事细胞异常代谢相关机制及中药的干预作用研究。 E-mail: 1029866417@qq.com
  • 作者简介:马旺博,男,硕士研究生,从事生化药理方向研究。 E-mail: 1119181461@qq.com
  • 基金资助:
    蚌埠医学院重大科技培育项目(2020byfy001);安徽省教育厅优秀青年人才支持计划重点项目(ZD2020027);国家自然基金(81973658,81603463);中国博士后基金(一等资助)(2018M640529)

Effects of Shenqi fuzheng injection on low-glucose-mediated immunosuppressive microenvironment and its mechanism of action

MA Wangbo1,2, Ma Yue1,2, FAN Fangtian1,2, ZHANG Yuhan1,2, CHANG Jingwen1,2, ZHOU Zhihua1,2   

  1. 1School of Pharmacy, Bengbu Medical College, Bengbu 233030, Anhui, China; 2Anhui Biochemical Drug Engineering Technology Research Center, Bengbu 233030, Anhui, China
  • Received:2021-11-08 Revised:2022-01-28 Online:2022-02-26 Published:2022-03-09

摘要: 目的:探讨参芪扶正注射液(Shenqi fuzheng injection, SFI)干预肿瘤免疫作用及初步分子机制研究。方法:采用B16-PKM2-OE建立低糖肿瘤微环境动物模型;采用ELISA试剂盒检测白细胞介素-2(IL-2),干扰素-γ(IFN-γ),CD40L和转化生长因子-β1(TGF-β1)的水平;采用Western blot法检测CD4+T细胞葡萄糖转运蛋白(Glut-1)和糖酵解关键酶(HK、PFK和PK)的表达。结果:试剂盒检测结果显示,SFI可以提高肿瘤组织中IL-2、IFN-γ、CD40L水平,降低TGF-β1的水平。Western blot法检测结果发现,SFI能够促进CD4+T细胞细胞膜表面Glut-1蛋白的表达,同时呈剂量依赖性上调糖酵解关键酶的表达。 结论:SFI能够升高肿瘤组织中的IL-2、IFN-γ和CD40L水平并降低TGF-β1水平,同时增加肿瘤组织里活化CD4+ T细胞的数量,促进CD4+T细胞的糖酵解,表明SFI能够改善肿瘤免疫微环境。

关键词: 肿瘤浸润淋巴细胞, 参芪扶正注射液, 低糖微环境

Abstract: AIM: To investigate the effect of Shenqi fuzheng injection (SFI) on tumor immunity and its preliminary molecular mechanism. METHODS: The animal model of low glucose tumor microenvironment was established by B16-PKM2-OE; the level of interleukin-2(IL-2) and interferon-γ(IFN-γ), CD40L and transforming growth factor-β1(TGF-β1) were detected by ELISA kit; the expressions of glucose transporter-1 (Glut-1) and key enzymes of glycolysis ( HK, PFK and PK ) in CD4+T cells were detected by Western blot. RESULTS: The results of the kit showed that SFI could increase IL-2, IFN-γ and CD40L, and decreased TGF-β1 in tumor tissues. Western blot assay showed that SFI could promote the expression of Glut-1 protein on the surface of CD4+T cell membrane, and up-regulated the expression of key enzymes of glycolysis (HK, PFK1 and PK) in a dose-dependent manner. CONCLUSION: SFI can increase the expression levels of IL-2, IFN-γ, CD40L and decrease the expression level of TGF-β1 in tumor tissues. Also, it increases the number of activated CD4+T cells in tumor tissue and promotes the glycolysis of CD4+T cells, indicating that SFI can improve the tumor immune microenvironment.

Key words: tumor infiltrating lymphocytes, Shenqi fuzheng injection, low sugar microenvironment

中图分类号: